EUVIMEDOpdag EUVIMED
Crossref

The Sigma‐1 Receptor as a Novel Target in the Neuroprotective Effects of Cannabidiol and Cannabigerol Against Mitochondrial Damage in Cultured Cerebellar Granule Neurons

Victoria Oviedo-Pino iD, Mariana Pazos iD, Giselle Prunell iD, Carlos Ferreiro-Vera, Verónica Sánchez de Medina, Miguel Reyes-Parada iD, David Ramírez iD, Cecilia Scorza iD, Carolina Echeverry iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70510 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Victoria Oviedo-Pino and 8 co-authors. Institution: Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile. Major MEDLINE topics: Receptors, sigma, Neuroprotective Agents, Cannabidiol, Neurons. 53 references. Funded by: Programa de Desarrollo de las Ciencias Básicas, Agencia Nacional de Investigación e Innovación, Departamento de Investigaciones Científicas y Tecnológicas, Universidad de Santiago de Chile.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cannabidiol (CBD) and cannabigerol (CBG) are nonpsychotomimetic phytocannabinoids with neuroprotective properties. We have previously reported that CBD and CBG, but not their acidic forms, protect cerebellar granule neurons from rotenone‐induced toxicity. These effects were independent of canonical (i.e., cannabinoid 1 and 2‐receptors) and noncanonical cannabinoid targets (i.e., transient‐receptor potential vanilloid type 1 or peroxisome proliferator‐activated receptor), suggesting alternative mechanisms. The sigma‐1 receptor (σ1R), a chaperone enriched at mitochondria‐associated membranes, regulates Ca 2+ homeostasis, oxidative stress, and mitochondrial function, representing a neuroprotective target. In this study, we investigated the role of σ1R in\ the neuroprotective actions of CBD and CBG using a rotenone‐induced neurotoxicity model in primary neuronal cultures. Pharmacological blockade of σ1R with NE‐100 abolished the neuroprotective effects of both cannabinoids, supporting a σ1R‐dependent mechanism. Consistently, molecular docking and molecular dynamics simulations using the human σ1R structure revealed stable binding of CBD and CBG within the ligand‐binding pocket, involving key residues for receptor recognition. According to the in vitro data, neutral forms showed higher predicted affinities than their acidic counterparts, while NE‐100 exhibited the strongest binding. These findings identify σ1R as a functionally relevant target for CBD and CBG, supporting their neuroprotective effects through modulation of σ1R‐mediated responses.

Subjects

MeSH terms (MEDLINE)

Receptors, sigmaNeuroprotective AgentsCannabidiolNeuronsCannabinoidsMitochondriaSigma-1 ReceptorAnimalsCerebellumCells, CulturedMolecular Docking SimulationRatsStructure-Activity RelationshipDose-Response Relationship, DrugMolecular Structure

Author keywords

cannabinoidsneurodegenerative diseasesneuroprotectionrotenone neurotoxicitysigma‐1 receptor

Substances

Receptors, sigmaSigma-1 ReceptorNeuroprotective AgentsCannabidiolCannabinoidscannabigerol

Authors and institutions

  • Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
  • Laboratorio de Mecanismos de Neurodegeneración y Neuroprotección, Departamento de Neurobiología y Neuropatología, Instituto de Investigaciones Biológicas Clemente Estable (IIBCE), Montevideo, Uruguay.
  • Neuroactive Natural Compounds UNESCO Chair, IIBCE, Montevideo, Uruguay.
  • Phytoplant Research S.L.U, Córdoba, Spain.
  • Centro de Investigación Biomédica y Aplicada (CIBAP), Escuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile.
  • Departamento de Neurofarmacología Experimental, IIBCE, Montevideo, Uruguay.

ORCID profiles: Victoria Oviedo-Pino, Mariana Pazos, Giselle Prunell, Miguel Reyes-Parada, David Ramírez, Cecilia Scorza, Carolina Echeverry

Funding

  • Programa de Desarrollo de las Ciencias Básicas
  • Agencia Nacional de Investigación e Innovación
  • Departamento de Investigaciones Científicas y Tecnológicas, Universidad de Santiago de Chile
  • Agencia Nacional de Investigación y Desarrollo

Cite

APA

Oviedo-Pino, V., Pazos, M., Prunell, G., Ferreiro-Vera, C., Sánchez de Medina, V., Reyes-Parada, M., Ramírez, D., Scorza, C., & Echeverry, C. (2026). The Sigma‐1 Receptor as a Novel Target in the Neuroprotective Effects of Cannabidiol and Cannabigerol Against Mitochondrial Damage in Cultured Cerebellar Granule Neurons. ChemMedChem. https://doi.org/10.1002/cmdc.70510

Vancouver

Oviedo-Pino V, Pazos M, Prunell G, Ferreiro-Vera C, Sánchez de Medina V, Reyes-Parada M, et al. The Sigma‐1 Receptor as a Novel Target in the Neuroprotective Effects of Cannabidiol and Cannabigerol Against Mitochondrial Damage in Cultured Cerebellar Granule Neurons. ChemMedChem. 2026. doi:10.1002/cmdc.70510

BibTeX
@article{OviedoPino2026,
  author = {Oviedo-Pino, Victoria and Pazos, Mariana and Prunell, Giselle and Ferreiro-Vera, Carlos and Sánchez de Medina, Verónica and Reyes-Parada, Miguel and Ramírez, David and Scorza, Cecilia and Echeverry, Carolina},
  title = {The Sigma‐1 Receptor as a Novel Target in the Neuroprotective Effects of Cannabidiol and Cannabigerol Against Mitochondrial Damage in Cultured Cerebellar Granule Neurons},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70510}
}
Start for free →